FP7 takes off

The EU's largest ever funding programme for research and technological development, the Seventh Framework Programme (FP7), was launched on 1 January.

The programme cleared its final hurdle when it was adopted by the Council on 18 December 2006. The decision was widely expected following an agreement on a common position between the Parliament and Council in November. The common position meant that the decision could be adopted by the Environment Council without discussion.

With a total budget of €50.521 billion, FP7 will run for of seven years. An additional €2.7 billion has been earmarked for the Euratom programme on nuclear research, which will run for five years. EU Science and Research Commissioner Janez Potocnik hailed the FP7's approval as 'great day' for European Science. 'In financial terms, this is a major improvement over the last framework programme. In real terms, there are 40 per cent more funds on average per year,' he said.

FP7 will aim to build on the accomplishments of the previous research framework programme, and will be implemented through four specific programmes. The 'Cooperation' programme will support research cooperation in a number of key thematic areas. 'Ideas' will fund investigator-driven research through a newly created European Research Council (ERC). The 'People' programme will support training and researchers' career development, while 'Capacities' will fund the coordination and development of research infrastructure, regional research clusters, international cooperation and closer ties between science and society.

Featuring simpler instruments and streamlined procedures for funding and participation, FP7 should facilitate the greater participation by and cooperation between universities, research centres, small and medium sized enterprises (SMEs) and companies on a broad range of research areas. In doing so, the new programme should make headway on the goal of creating a European Research Area (ERA) - the equivalent of a 'common market' for research - to become the world's leading research area.

Under FP7, the highest portion of the budget will go to information and communication technologies (€9.11 billion), followed by health (€6.05 billion), transport (€4.18 billion) and nanotechnology (€3.5 billion), energy (€2.3 billion), and food, agriculture and biotechnology (€1.935 billion). Other budget lines include environmental research (€1.8 billion), space (€1.43 billion), security (€1.35 billion), and social-economic sciences and humanities (€610 million).

Political discussions on FP7 were first held back by the lack of agreement on the EU's financial perspectives for 2007 to 2013. Consensus among the EU's Heads of State and Government on the overall budget was needed before the FP7 budget could be set.

Subsequent negotiations addressed ethical questions related to EU funding for human embryonic stem cell research, the structure of the ERC and the risk-sharing finance facility.

For further information, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...